News
| 6 min read
Millions of patients are now taking drugs like Ozempic and Wegovy, but clinicians still struggle to predict who will benefit and how best to support lasting results.
| 5 min read
Despite missing its primary endpoint, the trial shows a substantial reduction in stage four cancers and earlier detection across multiple tumor types.
| 2 min read
A large Japanese birth cohort study found that women who took antibiotics before or during early pregnancy were more likely to experience psychological distress.
| 4 min read
Oral FGFR3-targeted therapies are emerging as a potential step forward, offering more precise, convenient treatment options for children.
| 5 min read
ReiThera’s gorilla-derived adenovirus vector is helping advance vaccines and therapies for COVID-19, HIV, Ebola, and even cancer.
| 4 min read
At the Advanced Therapies conference, industry leaders showcased how in vivo CAR T cell and gene delivery innovations could transform accessibility and clinical outcomes.
| 5 min read
Harnessing multi-omics and AI, researchers are transforming drug discovery by revealing disease mechanisms, pinpointing therapeutic targets, and speeding up development.
| 5 min read
Pharma deals, newborn screening programs, FDA approvals, and more led the news this week.
| 4 min read
This new test offers clinicians a tool to detect endometriosis in patients whose lesions may be missed by standard imaging, helping address years-long delays in diagnosis.
| 4 min read
From early experiments in rare genetic diseases to next-generation tools that can edit, insert, and regulate genes, gene therapy is transforming what’s possible for patients.
| 2 min read
New spinal fluid biomarker distinguishes Parkinson's and Lewy body dementia from Alzheimer's disease
Immunoassays measuring DOPA decarboxylase in cerebrospinal fluid achieve high diagnostic accuracy.
| 5 min read
Industry leaders at the Advanced Therapies conference outline how early collaboration, funding, and culture shape whether breakthroughs reach patients.
